Aethlon Medical, Inc. (Nasdaq: AEMD) announced today that the company has concluded an FDA-approved feasibility study designed to assess ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE